Skip to content

Study About Contrast Media

Multicentre Randomized Trial on the Timing and Effect of Contrast Media on Patients with Adhesive Small Bowel Obstruction

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05678023
Enrollment
120
Registered
2023-01-10
Start date
2023-09-01
Completion date
2025-08-01
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Bowel Obstruction

Brief summary

Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.

Detailed description

Patients presenting with symptoms of small bowel obstruction (SBO) will be evaluated and if the diagnosis of adhesive small bowel obstruction is made it must be decided what is the treatment of choice. If immediate surgery is needed- it will not be delayed If patients are eligible for conservative management- they will be randomized to 2 study groups- contrast media (CM) after 4 hours of nasogastric-tube decompression and after 24 hours of nasogastric-tube decompression. Contrast media challenge acquires radiographs (X-rays) to be taken after an interval (common practice) decided by the surgeon. If at any point patient needs surgery- it will not be delayed. The results are compared. The hypothesis is, that if CM is administered sooner- it will help SBO resolution

Interventions

OTHEREffect on contrast media depending on the time of its administratsion

CM is a common practice when it comes to the management of small bowel obstruction. However there is no consensus as when it should be administered

Sponsors

North Estonia Medical Centre
CollaboratorOTHER
University of Tartu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Masking description

Sealed envelope randomisation

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients 18 years or older * Adhesive small bowel obstruction diagnosed (clinical, laboratory and radiologic evaluation * No peritonitis present, no need for an emergent surgery * Patients sign an informed consent

Exclusion criteria

* Patients younger than 18 yeas * Patients with mechanical small bowel obstruction caused by incarcerated hernias * Patients with mechanical small bowel obstruction caused by carcinomatosis * Patients with paralytic small bowel obstruction * Patients who have undergone surgery within 6 weeks * Patients who do not want to be enrolled in the study

Design outcomes

Primary

MeasureTime frameDescription
SBO resolutionPeriod of hospitalization- approximately 5 daysSBO resolution with conservative measures * passing gas * bowel movement * CM in the colon on the X-ray

Countries

Estonia

Contacts

Primary ContactLiis Jaanimäe, MD
liis.jaanimae@kliinikum.ee+3725224012
Backup ContactCeith Nikkolo, PhD
ceith.nikkolo@kliinikum.ee

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026